Page last updated: 2024-08-23

epirubicin and Invasiveness, Neoplasm

epirubicin has been researched along with Invasiveness, Neoplasm in 89 studies

Research

Studies (89)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's15 (16.85)18.2507
2000's28 (31.46)29.6817
2010's38 (42.70)24.3611
2020's8 (8.99)2.80

Authors

AuthorsStudies
Audenet, F; Brunelle, S; Compérat, E; Houédé, N; Lanz, C; Larré, S; Masson-Lecomte, A; Méjean, A; Neuzillet, Y; Pignot, G; Rollin, P; Roumiguié, M; Rouprêt, M; Xylinas, E1
Allory, Y; Audenet, F; Leon, P; Loriot, Y; Masson-Lecomte, A; Neuzillet, Y; Pradère, B; Roumiguié, M; Roupret, M; Saint, F; Seisen, T; Traxer, O; Xylinas, E1
Niu, X; Wang, T; Zhong, B1
Brummelhuis, ISG; Crezee, J; Witjes, JA1
Chen, L; Fu, Y; He, J; Liu, Z; Wang, S; Xia, T; Yao, N; Zhu, Y1
El-Kappany, H; El-Nahas, AR; El-Shabrawy, M; Harraz, AM; Osman, Y1
Bi, XJ; Cai, F; Fu, M; He, SY; Jia, LQ; Jing, M; Kong, L; Li, XT; Liu, JJ; Liu, XZ; Yao, XM; Zhang, L1
Chen, J; Chen, L; Huang, B; Huang, G; Li, W; Mao, X1
Adriaenssens, E; Angrand, PO; Bidan, N; Chopin, V; Lagadec, C; Le Bourhis, X; Meignan, S; Toillon, RA; Völkel, P; Winter, M1
Liu, Y; Shang, D; Song, B1
Chen, D; Huang, H; Lu, Y; Yang, H1
Cozar-Olmo, JM; Fernandez-Gomez, JM; Juárez, A; Martínez-Piñeiro, L; Palou, J; Unda-Urzaiz, M1
Liu, S; Qin, Y; Song, X; Sun, Z; Wang, Y; Yang, J; Yu, K; Zhang, S; Zhou, X1
Fu, H; Pan, Y; Zhang, J; Zhang, X1
Chen, J; Chen, L; Fan, W; Huang, B; Lin, H; Qiu, S; Wang, H; Yao, Z; Zheng, J1
Chen, W; Cui, W; Fan, W; Li, J; Lian, F; Liu, Y; Shen, L; Wang, Y; Zhao, Y1
Cai, FY; Fu, M; Gong, XQ; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Tang, W; Yao, XM1
Huang, L; Meng, L; Xu, Y; Zhang, W1
Aittomäki, K; Blomqvist, C; Carpén, O; Fagerholm, R; Heikkilä, P; Heikkinen, T; Khan, S; Korpela, T; Nevanlinna, H1
Bailey, IS; Byrne, JP; Curtis, NJ; Kelly, JJ; Noble, F; Underwood, TJ1
Hayashi, N; Kajiura, Y; Matsuda, N; Nakamura, S; Ohde, S; Suzuki, K; Tsunoda, H; Yagata, H; Yamauchi, H; Yoshida, A1
Cartei, F; Cocuzza, P; Colosimo, C; Fiorica, F; Greco, C; Mazzotti, V; Pedriali, M; Stefanelli, A; Taibi, R; Ursino, S1
Ju, RJ; Li, XT; Li, XY; Liu, L; Lu, WL; Shi, JF; Sun, MG; Zeng, F; Zhang, CX; Zhao, WY; Zhou, J1
Brausi, MA; de Reijke, TM; Kirkels, WJ; Oddens, JR; Oosterlinck, W; Prescott, S; Sylvester, RJ; van Andel, G; van de Beek, C; Witjes, JA1
Anderson, A; Davidenko, I; Deptala, A; Donehower, RC; Dubey, S; Harrison, M; Iveson, T; Jiang, Y; Lakshmaiah, K; Loh, E; Nirni, S; Oliner, KS; Tang, R; Thomas, A; Tjulandin, S; Zhu, M1
Abraham, J; Basu, B; Brenton, J; Earl, H; Freeman, S; Gounaris, I; Hatcher, H; Hosking, K; Iddawela, M; Jimenez-Linan, M; Moyle, P; Parkinson, C; Sayal, K1
Hashimoto, Y; Hatakeyama, S; Hosogoe, S; Imai, A; Koie, T; Mori, K; Ohyama, C; Tobisawa, Y; Yamamoto, H; Yoneyama, T1
Ju, RJ; Li, XT; Li, XY; Lu, WL; Mu, LM; Shi, JF; Sun, MG; Yan, Y; Zeng, F; Zhao, Y1
Au, HJ; Bies, RR; Carandang, D; Cass, CE; Clemons, M; Damaraju, S; Damaraju, VL; Hanson, J; Joy, AA; King, K; Koski, S; Kuzma, M; Mackey, JR; Pituskin, E; Prado, CM; Sawyer, MB; Scarfe, AG; Smylie, M; Tonkin, K; Vos, LJ1
Aaltomaa, S; Boström, P; Hellström, P; Järvinen, R; Kaasinen, E; Leskinen, M; Liukkonen, T; Marttila, T; Raitanen, M; Rintala, E; Seppänen, M; Tammela, T1
Du, J; Fan, L; Jiang, J; Liang, Q; Liu, J; Ming, J; Zhang, Y; Zhong, L1
Cui, H; Jiang, R; Li, X; Lin, X; Liu, C; Tao, R; Tian, S; Zhuang, H; Zhuo, C1
Alunni-Fabbroni, M; Andergassen, U; Camara, O; de Gregorio, N; Decker, T; Fasching, PA; Fehm, TN; Friedl, TWP; Heinrich, G; Jaeger, B; Janni, W; Mahner, S; Ober, A; Pantel, K; Rack, BK; Schneeweiss, A; Schochter, F; Schramm, A; Trapp, E1
Adell, L; Bendahl, PO; Davidsson, T; Grabe, M; Gudjónsson, S; Hagberg, G; Larsson, B; Liedberg, F; Månsson, W; Merdasa, F; Olsson, R; Richthoff, J1
Goya, N; Hashimoto, Y; Iida, S; Kobayashi, H; Kondo, T; Tanabe, K1
Airoldi, M; Beatrice, F; Condello, C; Gabriele, AM; Garzaro, M; Giordano, C; Pecorari, G; Raimondo, L1
Gu, YJ; Guo, X; Guo, Y; Lu, H; Ma, X; Pang, Z; Wang, B1
Arii, S; Ikai, I; Kojiro, M; Kudo, M; Makuuchi, M; Matsuyama, Y; Takayasu, K1
Atkins, CD1
Bertheau, P; Brain, E; Delaloge, S; Espié, M; Guinebretière, JM; Marty, M; Mathieu, MC; Pierga, JY; Savignoni, A; Sigal-Zafrani, B; Spielmann, M1
Ebert, M; Grenacher, L; Lordick, F; Moehler, M; Röcken, C; Schumacher, G1
Ah-See, ML; Beresford, MJ; Collins, DJ; d'Arcy, JA; Li, SP; Makris, A; Padhani, AR; Stirling, JJ; Taylor, NJ1
Song, ST1
Akaza, H; Hinotsu, S; Koga, H; Kume, H; Nagamori, S; Naito, S; Nasu, Y; Noguchi, S; Ozono, S; Samma, S; Sumiyoshi, Y; Tanaka, Y; Terai, A; Tomita, Y; Tsushima, T; Uemura, H; Yamaguchi, A1
Han, B; Liu, H; Ruan, Y; Sun, X; Xia, S; Xue, S1
Beck, T; Camara, O; du Bois, A; Fasching, PA; Fett, W; Harbeck, N; Hasmüller, S; Höss, C; Kahlert, S; Konecny, GE; Kreienberg, R; Kühn, T; Lebeau, A; Loibl, S; Mehta, KM; Müller, V; Stickeler, E; Untch, M; von Minckwitz, G1
Cao, M; Chen, HG; Ma, CK; Ma, J; Xue, W1
Kordek, R; Kusinska, R; Majsterek, I; Przybylowska-Sygut, K; Stanczyk, M1
Ieda, N; Pirovano, C; Siesto, G; Vitobello, D1
Chow, LW; Glück, S; Im, SA; Lee, MH; Ng, TY; Toi, M; Tung, SY; Yip, AY1
Brundage, M; Chin, JL; Lukka, H; Markman, BR; Segal, R; Winquist, E1
Bisagni, G; Camisa, R; Canaletti, R; Carlini, P; Cocconi, G; Cognetti, F; Di Costanzo, F; Gamboni, A; Gasperoni, S; Porrozzi, S; Pucci, F; Rodinò, C; Ruggeri, EM; Zironi, S1
Habuchi, T; Kamoto, T; Nakashima, M; Nishiyama, H; Ogawa, O; Yagihashi, Y; Yamamoto, S1
Bielawski, KP; Bosse, U; Schlotter, CM; Vogt, U1
Barats, JC; Bonneterre, J; Campone, M; Chapelle-Marcillac, I; Fargeot, P; Goudier, MJ; Guastalla, JP; Lortholary, A; Monnier, A; Namer, M; Roché, H; Schraub, S; Van Praagh, I1
Bartsch, R; Gnant, MF; Hussian, D; Jakesz, R; Locker, GJ; Pluschnig, U; Sevelda, U; Steger, GG; Wenzel, C; Zielinski, CC1
Fujimoto, K; Fukushima, M; Hirao, Y; Matsui, Y; Nishiyama, H; Ogawa, O; Ohshima, S; Ono, Y; Teramukai, S; Watanabe, J1
Ito, S; Kariya, S; Moriki, T; Murata, Y; Nishioka, A; Ogawa, Y; Ohnishi, T; Yoshida, S1
Alliot, C1
Hitzl, W; Peintinger, F; Prokop, E; Reitsamer, R1
Amici, S; Gasparini, G; Gattuso, D; Gion, M; Longo, R; Sarmiento, R; Zancan, M1
Alberti, S; Angelucci, D; Cianchetti, E; Ficorella, C; Iacobelli, S; Lattanzio, R; Marchetti, P; Natoli, C; Piantelli, M; Ricevuto, E; Tinari, N1
Franke, FE; Hackethal, A; Münstedt, K; Von Georgi, R; Woenckhaus, J1
Fujii, M; Hirota, S; Maruta, T; Matsumoto, S; Nakanishi, K; Ohno, Y; Saigo, K; Sugimura, K; Takenaka, D; Yoshikawa, T1
Angellier, E; Berdah, JF; Buyse, M; Fabbro, M; Greget, S; Herait, P; Jehl, V; Laplaige, P; Piedbois, P; Priou, F; Serin, D; Teissier, E; Valenza, B1
Ren, YL; Shen, L; Wang, HY; Yang, WT1
Ames, FC; Babiera, GV; Feig, BW; Francis, A; Gilcrease, MZ; Hunt, KK; Kuerer, HM; Meric-Bernstam, F; Ross, MI; Shen, J1
Aitini, E; Ardizzoia, A; Arnoldi, E; Barni, S; Barone, C; Beretta, GD; Bertetto, O; Carnaghi, C; Cascinu, S; Cassano, A; Catalano, V; Chiara, S; Cortesi, E; Floriani, I; Foa, P; Frontini, L; Gasparini, G; Giordani, P; Labianca, R; Mansutti, M; Mosconi, S; Nardi, M; Piazza, E; Pozzo, C; Pucci, F; Rabbi, C; Ravaioli, A; Rimassa, L; Rota, S; Santoro, A; Silva, RR; Sobrero, A; Torri, V1
Hagihara, A; Ikeda, M; Iwasa, S; Kojima, Y; Morizane, C; Okusaka, T; Ueno, H1
Baldan, A; Burra, P; Cardin, R; Cillo, U; Cristofori, C; Farinati, F; Giacomin, A; Girardi, L; Pivetta, G; Ragazzi, R; Sergio, A1
Caris, CT; de Bruin, MJ; Hendricksen, K; Idema, JG; Janzing-Pastors, MH; Kums, JJ; van Vierssen Trip, OB; Vergunst, H; Witjes, JA; Witjes, WP1
Bartoletti, R; Boddi, V; Cai, T; Mazzoli, S; Mondaini, N; Nesi, G; Tinacci, G; Zini, E1
Chuchkova, M; Damianov, C; Koleva, P; Terziev, T1
Ikenaga, M; Kikkawa, N; Kobayashi, K; Mishima, H; Morita, T; Shin, E; Takatsuka, Y; Tamaki, Y; Touno, T; Yagyu, T1
Kobayashi, H; Obata, K1
Cevoli, R; Cocimano, V; Marino, G; Marten Perolino, R1
Chionis, HS; Dauaher, HH; Melekos, MD; Paranychianakis, GS1
Fujinaga, H; Kume, K; Matsuzaka, T; Ono, E; Wakasugi, K; Yano, M1
Kawaguchi, T; Nishimura, S; Takahashi, N1
Akyüz, C; Berberoğlu, S; Büyükpamukçu, M1
Ali-el-Dein, B; Aly, AN; Ashamallah, A; el-Baz, M; Shamaa, S1
Hubmer, G; Lehnert, M; Pummer, K; Stettner, H1
Kroeger, N; Kupper, H; Lehnert, M; Mross, K; Schueller, J; Thuerlimann, B1
Chauvergne, J; Fervers, B; Fondrinier, E; Guastalla, JP; Haie-Meder, C; Lhommé, C; Resbeut, M1
Griffiths, TR; Hall, RR; Lunec, J; Marsh, C; Neal, DE; Qureshi, KN; Roberts, JT; Robinson, MC1
Fischer, C; Lehmann, J; Loch, T; Pinkenburg, FA; Retz, M; Seppelt, U; Stöckle, M; Timm, KJ; Trocha, C; Wellek, S1
Baba, K; Fukuda, M; Matsuda, M; Matsuoka, Y; Miyayama, H; Nagao, K; Nishimura, R; Yamashita, H1
Furukawa, Y; Hayashi, J; Hidaka, N; Kato, M; Ohashi, N; Sanda, M; Yajima, Y1
Newling, DW1

Reviews

6 review(s) available for epirubicin and Invasiveness, Neoplasm

ArticleYear
Nucleolar and Spindle Associated Protein 1 (NUSAP1) Inhibits Cell Proliferation and Enhances Susceptibility to Epirubicin In Invasive Breast Cancer Cells by Regulating Cyclin D Kinase (CDK1) and DLGAP5 Expression.
    Medical science monitor : international medical journal of experimental and clinical research, 2018, Nov-26, Volume: 24

    Topics: Apoptosis; Breast Neoplasms; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; MCF-7 Cells; Microtubule-Associated Proteins; Neoplasm Invasiveness; Neoplasm Proteins; RNA, Messenger; Transcriptome

2018
Anaplastic thyroid cancer: a case report of a long term survival patient and review of literature data.
    European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Humans; Male; Middle Aged; Neoplasm Invasiveness; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2014
Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: a network meta-analysis.
    Oncotarget, 2016, Dec-13, Volume: 7, Issue:50

    Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; BCG Vaccine; Deoxycytidine; Disease Progression; Epirubicin; Female; Gemcitabine; Humans; Isoniazid; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms

2016
[Diagnosis and treatment of gastric cancer].
    Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:34-35

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Signet Ring Cell; Cisplatin; Endoscopy, Digestive System; Epirubicin; Esophagectomy; Fluorouracil; Gastrectomy; Gastric Mucosa; Humans; Laparoscopy; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm, Residual; Stomach Neoplasms; Tomography, X-Ray Computed

2010
[A case report of a young patient with invasive bladder cancer].
    Hinyokika kiyo. Acta urologica Japonica, 2003, Volume: 49, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Humans; Male; Methotrexate; Neoplasm Invasiveness; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urinary Diversion

2003
[Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
    Bulletin du cancer, 1999, Volume: 86, Issue:10

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Humans; Hydroxyurea; Lymphatic Metastasis; Multicenter Studies as Topic; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Practice Guidelines as Topic; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms

1999

Trials

31 trial(s) available for epirubicin and Invasiveness, Neoplasm

ArticleYear
Single Versus Maintenance Intravesical Chemotherapy for the Prevention of Bladder Recurrence after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Randomized Clinical Trial.
    Clinical genitourinary cancer, 2019, Volume: 17, Issue:6

    Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Drug Administration Schedule; Epirubicin; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Nephroureterectomy; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms

2019
Randomized controlled trial of late-course concurrent versus sequential chemoradiotherapy after mastectomy and axillary surgery in locally advanced breast cancer.
    Medicine, 2017, Volume: 96, Issue:41

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemoradiotherapy; Cyclophosphamide; Docetaxel; Dose Fractionation, Radiation; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Mastectomy; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Taxoids; Treatment Outcome

2017
Evaluation of the effects of intra-arterial chemotherapy combined with intravesical chemotherapy against intravesical chemotherapy alone after transurethral resection of bladder tumor in T1-staged Grade 3 bladder cancer.
    Journal of cancer research and clinical oncology, 2019, Volume: 145, Issue:2

    Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Injections, Intra-Arterial; Male; Middle Aged; Muscle Neoplasms; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Urinary Bladder Neoplasms

2019
The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
    European urology, 2014, Volume: 66, Issue:4

    Topics: Age Factors; Aged; Aged, 80 and over; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cystectomy; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Proportional Hazards Models; Risk Assessment; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms

2014
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
    The Lancet. Oncology, 2014, Volume: 15, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Confidence Intervals; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Proportional Hazards Models; Stomach Neoplasms; Survival Rate; Treatment Outcome

2014
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:6

    Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Endometrial Neoplasms; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Retrospective Studies; Survival Rate

2015
Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study.
    European urology, 2016, Volume: 70, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antibiotics, Antineoplastic; BCG Vaccine; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Recombinant Proteins; Survival Analysis; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms

2016
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
    Clinical breast cancer, 2017, Volume: 17, Issue:4

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Prevalence; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Taxoids; Young Adult

2017
Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.
    European urology, 2009, Volume: 55, Issue:4

    Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Epirubicin; Female; Humans; Male; Neoplasm Invasiveness; Postoperative Care; Prospective Studies; Time Factors; Urinary Bladder Neoplasms; Urologic Surgical Procedures

2009
Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2009, Volume: 92, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Epirubicin; Female; Humans; Male; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Treatment Outcome

2009
A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2009, Volume: 93, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Invasiveness; Nose Neoplasms; Pharyngeal Neoplasms; Prednisone; Prognosis; Radiation Injuries; Semustine; Survival Rate; Vincristine; Young Adult

2009
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.
    Breast cancer research and treatment, 2010, Volume: 122, Issue:2

    Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Celecoxib; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; France; Humans; In Situ Hybridization, Fluorescence; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Pyrazoles; Receptor, ErbB-2; Sulfonamides; Taxoids; Therapeutics; Time Factors; Trastuzumab

2010
Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer.
    BJU international, 2011, Volume: 108, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Intravesical; Adult; Aged; Antineoplastic Agents; BCG Vaccine; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Epidemiologic Methods; Epirubicin; Female; Humans; Male; Middle Aged; Mycobacterium bovis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Treatment Outcome; Urinary Bladder Neoplasms; Young Adult

2011
Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Sep-01, Volume: 29, Issue:25

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Paclitaxel; Prospective Studies; Receptor, ErbB-2; Remission Induction; Survival Rate; Trastuzumab; Treatment Outcome; Young Adult

2011
[Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:5

    Topics: Administration, Intravesical; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms

2011
Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II - III invasive breast cancer: the OOTR-N001 study.
    Expert opinion on investigational drugs, 2013, Volume: 22, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Celecoxib; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Phenobarbital; Prospective Studies; Pyrazoles; Receptor, ErbB-2; Sulfonamides; Taxoids

2013
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Confidence Intervals; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Italy; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Prognosis; Stomach Neoplasms; Survival Analysis; Treatment Outcome

2003
Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Dec-01, Volume: 22, Issue:23

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Maximum Tolerated Dose; Menopause; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Risk Assessment; Survival Rate; Tamoxifen; Treatment Outcome

2004
Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer.
    Anti-cancer drugs, 2005, Volume: 16, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Epirubicin; Female; Filgrastim; Fluorouracil; Glucuronates; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Pilot Projects; Polyethylene Glycols; Preoperative Care; Prospective Studies; Receptor, ErbB-2; Recombinant Proteins; Taxoids; Treatment Outcome

2005
Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer.
    Anti-cancer drugs, 2005, Volume: 16, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Glucuronates; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Prospective Studies; Receptor, ErbB-2; Remission Induction; Taxoids; Treatment Outcome

2005
Gefitinib (ZD1839) combined with weekly epirubicin in patients with metastatic breast cancer: a phase I study with biological correlate.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Epirubicin; ErbB Receptors; Female; Gefitinib; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Quinazolines; Receptor, ErbB-2

2005
Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 rando
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Feasibility Studies; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Survival Rate; Taxoids; Treatment Outcome

2007
Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Journal of the National Cancer Institute, 2007, Apr-18, Volume: 99, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Stomach Neoplasms; Survival Analysis

2007
Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer.
    European urology, 2008, Volume: 53, Issue:5

    Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Cystoscopy; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prospective Studies; Treatment Outcome; Urinary Bladder Neoplasms

2008
Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study.
    The Journal of urology, 2008, Volume: 180, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; BCG Vaccine; Double-Blind Method; Drug Synergism; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Prospective Studies; Risk Factors; Time Factors; Urinary Bladder Neoplasms

2008
Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors.
    Anti-cancer drugs, 1994, Volume: 5, Issue:3

    Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunotherapy, Active; Lomustine; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednimustine; Urinary Bladder Neoplasms; Vinblastine

1994
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
    Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine

1994
Intravesical 4'-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer.
    Cancer, 1993, Sep-01, Volume: 72, Issue:5

    Topics: Administration, Intravesical; Aged; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystitis; Epirubicin; Female; Follow-Up Studies; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Remission Induction; Urinary Bladder Neoplasms

1993
Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    The Journal of urology, 1997, Volume: 158, Issue:1

    Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Disease Progression; Doxorubicin; Epirubicin; Female; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Urinary Bladder Neoplasms

1997
Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.
    European urology, 1997, Volume: 32 Suppl 3

    Topics: Aged; Androgen Antagonists; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Epirubicin; Flutamide; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Software; Treatment Outcome

1997
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.
    British journal of cancer, 1998, Volume: 77, Issue:7

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Blood Pressure; Breast Neoplasms; Calcium Channel Blockers; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Middle Aged; Neoplasm Invasiveness; Treatment Outcome; Verapamil

1998

Other Studies

52 other study(ies) available for epirubicin and Invasiveness, Neoplasm

ArticleYear
[Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2022, Volume: 32, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antibiotics, Antineoplastic; BCG Vaccine; Clinical Protocols; COVID-19 Drug Treatment; Epirubicin; Female; Humans; Male; Mitomycin; Neoplasm Invasiveness; Retrospective Studies; Urinary Bladder Neoplasms

2022
[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2022, Volume: 32, Issue:5

    Topics: Administration, Intravesical; Antibiotics, Antineoplastic; BCG Vaccine; Epirubicin; Female; Humans; Male; Mitomycin; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Urology

2022
Molecular classification of patients with NMIBC predicts the efficacy of intravesical chemotherapy with pirarubicin, pharmorubicin and gemcitabine-immunohistochemistry-based classification.
    Japanese journal of clinical oncology, 2022, May-31, Volume: 52, Issue:6

    Topics: Administration, Intravesical; Anthracyclines; Antibiotics, Antineoplastic; Deoxycytidine; Doxorubicin; Epirubicin; Gemcitabine; Humans; Immunohistochemistry; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms

2022
Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2023, Volume: 40, Issue:1

    Topics: Combined Modality Therapy; Epirubicin; Humans; Hyperthermia, Induced; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms

2023
Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis.
    Oncogene, 2019, Volume: 38, Issue:47

    Topics: Breast Neoplasms; Cell Movement; Drug Resistance, Neoplasm; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; MicroRNAs; Neoplasm Invasiveness; Nuclear Proteins; RNA, Long Noncoding; Twist-Related Protein 1

2019
Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis.
    Drug development and industrial pharmacy, 2020, Volume: 46, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Chick Embryo; Chorioallantoic Membrane; Cyclooctanes; Epirubicin; Female; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Polycyclic Compounds; Xenograft Model Antitumor Assays

2020
Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral resection of the bladder tumor.
    Journal of cancer research and clinical oncology, 2021, Volume: 147, Issue:6

    Topics: Adjuvants, Immunologic; Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Epirubicin; Female; Humans; Immunotherapy; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Invasiveness; Retrospective Studies; Risk Factors; Urinary Bladder Neoplasms

2021
Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment.
    Cells, 2021, 06-15, Volume: 10, Issue:6

    Topics: Animals; Cell Line, Tumor; Cell Movement; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Therapy; Epirubicin; Epithelial-Mesenchymal Transition; Female; Humans; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paclitaxel; Triple Negative Breast Neoplasms; Vimentin; Zebrafish

2021
Epirubicin suppresses proliferative and metastatic potential by downregulating transforming growth factor-β-induced expression in urothelial carcinoma.
    Cancer science, 2018, Volume: 109, Issue:4

    Topics: Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; RNA, Messenger; Transforming Growth Factor beta; Up-Regulation; Urologic Neoplasms; Urothelium

2018
Update on the role of endovesical chemotherapy in nonmuscle-invasive bladder cancer.
    Actas urologicas espanolas, 2018, Volume: 42, Issue:2

    Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Epirubicin; Humans; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Practice Guidelines as Topic; Urinary Bladder Neoplasms

2018
Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
    International journal of molecular medicine, 2018, Volume: 42, Issue:1

    Topics: Adipocytes; Adult; Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemokine CCL5; Coculture Techniques; Emodin; Epirubicin; Epithelial-Mesenchymal Transition; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Signal Transduction; Triple Negative Breast Neoplasms

2018
Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer.
    Journal of cancer research and clinical oncology, 2019, Volume: 145, Issue:6

    Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Cystectomy; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms

2019
Development of R
    Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1

    Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Drug Liberation; Epirubicin; Humans; Lipid Bilayers; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Polyethylene Glycols; Xenograft Model Antitumor Assays

2019
Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin.
    Cancer chemotherapy and pharmacology, 2020, Volume: 85, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; China; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Incidence; Lung Diseases, Interstitial; Middle Aged; Neoplasm Invasiveness; Polyethylene Glycols; Prognosis; Retrospective Studies

2020
Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
    Breast cancer research and treatment, 2013, Volume: 141, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Eukaryotic Initiation Factor-4E; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Proteins; Paraffin Embedding; Phenotype; Prognosis; Protein Biosynthesis; Tissue Array Analysis; Treatment Outcome; Triple Negative Breast Neoplasms

2013
The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction.
    Journal of surgical oncology, 2014, Volume: 109, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anastomotic Leak; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Databases, Factual; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Hospitals, University; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Predictive Value of Tests; Prognosis; Prospective Studies; Stomach Neoplasms; United Kingdom

2014
A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
    Journal of surgical oncology, 2014, Volume: 109, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Nomograms; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; ROC Curve; Survival Rate; Taxoids

2014
Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
    Biomaterials, 2014, Volume: 35, Issue:26

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Drug Delivery Systems; Epirubicin; Female; HIV-1; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptides; Phosphatidylethanolamines; Polyethylene Glycols; Pyrazoles; Sulfonamides

2014
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    International urology and nephrology, 2015, Volume: 47, Issue:9

    Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Cystoscopy; Disease Progression; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Natural Orifice Endoscopic Surgery; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome; Urethra; Urinary Bladder Neoplasms

2015
Targeting Epirubicin Plus Quinacrine Liposomes Modified with DSPE-PEG2000-C(RGDfK) Conjugate for Eliminating Invasive Breast Cancer.
    Journal of biomedical nanotechnology, 2015, Volume: 11, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Epirubicin; Female; Humans; Liposomes; Mice; Mice, Inbred BALB C; Nanocapsules; Nanoconjugates; Neoplasm Invasiveness; Particle Size; Peptides, Cyclic; Phosphatidylethanolamines; Polyethylene Glycols; Quinacrine; Treatment Outcome

2015
A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.
    Clinical breast cancer, 2016, Volume: 16, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Genotype; Glucuronosyltransferase; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Polymorphism, Single Nucleotide; Prognosis; Prospective Studies; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate

2016
Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment.
    World journal of surgical oncology, 2016, Jun-22, Volume: 14, Issue:1

    Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Medullary; Case-Control Studies; Charcoal; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Nanoparticles; Neoplasm Invasiveness; Neoplasm Staging; Prognosis

2016
Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience.
    International journal of urology : official journal of the Japanese Urological Association, 2009, Volume: 16, Issue:3

    Topics: Administration, Intravesical; Aged; Aged, 80 and over; BCG Vaccine; Carcinoma, Transitional Cell; Cause of Death; Chemotherapy, Adjuvant; Cohort Studies; Combined Modality Therapy; Cystectomy; Epirubicin; Female; Follow-Up Studies; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Staging; Probability; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms

2009
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    AJR. American journal of roentgenology, 2010, Volume: 194, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Diagnostic Imaging; Doxorubicin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Logistic Models; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Surveys and Questionnaires; Survival Rate; Treatment Outcome; Zinostatin

2010
Optimal chemotherapy for high-risk early-stage breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jun-01, Volume: 28, Issue:16

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Maximum Tolerated Dose; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prognosis; Risk Assessment; Survival Analysis; Treatment Outcome

2010
Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
    Radiology, 2010, Volume: 257, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Contrast Media; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; ROC Curve; Statistics, Nonparametric; Taxoids

2010
[Practice and consideration on neoadjuvant therapy for early breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tumor Burden

2010
2-micrometer continuous wave laser treatment for multiple non-muscle-invasive bladder cancer with intravesical instillation of epirubicin.
    Lasers in surgery and medicine, 2011, Volume: 43, Issue:1

    Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Epirubicin; Female; Humans; Laser Therapy; Male; Middle Aged; Neoplasm Invasiveness; Urinary Bladder Neoplasms

2011
Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer.
    Clinical breast cancer, 2013, Volume: 13, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; DNA Repair; DNA-Binding Proteins; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Immunoenzyme Techniques; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Survival Rate; X-ray Repair Cross Complementing Protein 1

2013
Surgical outcomes of robotic radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer: comparison with early stage disease.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2013, Volume: 39, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Dose Fractionation, Radiation; Epirubicin; Feasibility Studies; Female; Humans; Hysterectomy; Ifosfamide; Laparoscopy; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiotherapy, Adjuvant; Robotics; Safety; Treatment Outcome; Uterine Cervical Neoplasms; Vagina

2013
Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    The Canadian journal of urology, 2002, Volume: 9, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystectomy; Doxorubicin; Epirubicin; Evidence-Based Medicine; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine

2002
Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.
    Oncology reports, 2004, Volume: 12, Issue:5

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cyclophosphamide; Diphosphonates; Docetaxel; Drug Synergism; Epirubicin; Female; Fluorouracil; Humans; Ibandronic Acid; Imidazoles; In Vitro Techniques; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasms, Ductal, Lobular, and Medullary; Paclitaxel; Taxoids; Zoledronic Acid

2004
The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.
    International journal of clinical oncology, 2005, Volume: 10, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Epirubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine

2005
Relationship between hormonal receptors, HER-2, p53 protein, Bcl-2, and MIB-1 status and the antitumor effects of neoadjuvant anthracycline-based chemotherapy in invasive breast cancer patients.
    Radiation medicine, 2005, Volume: 23, Issue:3

    Topics: Adult; Aged; Analysis of Variance; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tumor Suppressor Protein p53

2005
Weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jun-20, Volume: 23, Issue:18

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Maximum Tolerated Dose; Menopause; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Risk Assessment; Survival Rate; Tamoxifen; Treatment Outcome

2005
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Mar-01, Volume: 12, Issue:5

    Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Proto-Oncogene Mas; Receptor, ErbB-2; Stereoisomerism

2006
Glucocorticosteroid receptors in ovarian carcinomas.
    Oncology reports, 2006, Volume: 15, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Glucocorticoids; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Receptors, Glucocorticoid; Survival Rate

2006
Anticoagulant-induced pseudothrombocytopenia occurring after transcatheter arterial embolization for hepatocellular carcinoma.
    Japanese journal of clinical oncology, 2006, Volume: 36, Issue:8

    Topics: Aged; Antibiotics, Antineoplastic; Anticoagulants; Blood Platelets; Carcinoma, Hepatocellular; Disseminated Intravascular Coagulation; Edetic Acid; Embolization, Therapeutic; Epirubicin; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Neoplasm Invasiveness; Platelet Count; Portal Vein; Thrombocytopenia

2006
[Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma].
    Zhonghua fu chan ke za zhi, 2006, Volume: 41, Issue:12

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Endometrial Neoplasms; Epirubicin; Female; Humans; Hysterectomy; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Retrospective Studies; Survival Rate; Uterine Neoplasms

2006
Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Cancer, 2007, Apr-01, Volume: 109, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Doxorubicin; Epirubicin; False Negative Reactions; Feasibility Studies; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Preoperative Care; Sentinel Lymph Node Biopsy; Time Factors; Ultrasonography, Mammary

2007
Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
    Oncology, 2007, Volume: 72, Issue:3-4

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Portal Vein; Retrospective Studies; Survival Analysis; Venous Thrombosis

2007
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    The American journal of gastroenterology, 2008, Volume: 103, Issue:4

    Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Enzyme-Linked Immunosorbent Assay; Epirubicin; Female; Fibroblast Growth Factor 2; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Prognosis; Proportional Hazards Models; Statistics, Nonparametric; Survival Rate; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A

2008
[A case of advanced gastric cancer successfully treated with resection after FEP (5-FU, epirubicin, CDDP) combined chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:15

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Invasiveness; Stomach Neoplasms

1994
[Adjuvant chemotherapy in infiltrating bladder carcinoma. Long-term results].
    Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1993, Volume: 45, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Urinary Bladder Neoplasms; Vinblastine

1993
[A case of giant advanced breast cancer responding remarkably to CEFT therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Middle Aged; Neoplasm Invasiveness; Tamoxifen; Thoracic Neoplasms

1993
Intra-arterial chemotherapy for muscle-invasive urinary bladder cancer.
    Hinyokika kiyo. Acta urologica Japonica, 1996, Volume: 42, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Tomography, Emission-Computed, Single-Photon; Urinary Bladder Neoplasms; Vinblastine

1996
Successful treatment of intracaval and atrial extension of Wilms' tumour by chemotherapy.
    Postgraduate medical journal, 1996, Volume: 72, Issue:854

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Dactinomycin; Epirubicin; Heart Atria; Humans; Kidney Neoplasms; Male; Neoplasm Invasiveness; Vena Cava, Inferior; Vincristine; Wilms Tumor

1996
TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Multiple; Epirubicin; Female; Genes, p53; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Predictive Value of Tests; Prognosis; Retrospective Studies; Survival Rate; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Vinblastine

1999
Long term follow-up of combined radiochemotherapy for locally advanced bladder carcinoma.
    Cancer, 2000, Sep-01, Volume: 89, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Invasiveness; Patient Compliance; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms

2000
An evaluation of predictive factors involved in clinical or pathological response to primary chemotherapy in advanced breast cancer.
    Breast cancer (Tokyo, Japan), 2002, Volume: 9, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Logistic Models; Mastectomy, Segmental; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Prognosis; Survival Rate; Treatment Outcome

2002
[A effective combination preoperative intraarterial infusion chemotherapy and irradiation for advanced sigmoid colon cancer with bladder invasion].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1992, Volume: 89, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Humans; Infusions, Intra-Arterial; Iodized Oil; Male; Middle Aged; Neoplasm Invasiveness; Preoperative Care; Sigmoid Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms

1992
Organ conservation in bladder cancer.
    Progress in clinical and biological research, 1991, Volume: 370

    Topics: Administration, Intravesical; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Humans; Mitomycin; Neoplasm Invasiveness; Urinary Bladder Neoplasms

1991